Erythrocytosis in Dogs and Cats: Diagnosis and Management

Compendium on Continuing Education for the Practicing Veterinarian

Volumn 26, Issue 2, 2004, Pages 104-118

  Kelly Nitsche, E ^a  

^a Animal Cancer Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; CANIS FAMILIARIS; FELIS CATUS;

EID: 1542290693     PISSN: 01931903     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Miller RM: Polycythemia vera in a dog. Vet Med Small Anim Clin 63:222-223, 1968.
2. Carb AV: Polycythemia vera in a dog. JAVMA 154:289-297, 1969.
3. Bush BM, Fankhauser R: Polycythemia vera in a bitch. J Small Anim Pract 13:75-89, 1972.
4. Scott RC, Patnaik AK: Renal carcinoma associated with secondary polycythemia in the dog. JAAHA 8:275-283, 1972.
5. MCGrath CJ: Polycythemia vera in dogs. JAVMA 164:1117-1122, 1974.
6. Peterson ME, Zanjani ED: Inappropriate erythropoietin production from a renal carcinoma in a dog with polycythemia. JAVMA 179:995-996, 1981.
7. MCGrath CJ, Krawiec DR, Johnston SD: Canine polycythemia vera: A review of diagnostic features. Vet Med Small Anim Clin 77:611-613, 1982.
8. Nelson RW, Hager D, Zanjani ED: Renal lymphosarcoma with inappropriate erythropoietin production in a dog. JAVMA 182:1396-1397, 1983.
9. Waters DJ, Prueter JC: Secondary polycythemia associated with renal disease in the dog: Two case reports and review of literature. JAAHA 24:109-114, 1988.
10. Gorse MJ: Polycythemia associated with renal fibrosarcoma in a dog. JAVMA 192:793-794, 1988.
11. Ware WA, Bonagura JD: Multiple congenital cardiac anomalies and Eisenmenger's syndrome in a dog. Compend Contin Educ Pract Vet 10:932-937, 949, 1988.
12. Foster ES, Lothrop Jr CD: Polycythemia vera in a cat with cardiac hypertrophy. JAVMA 192:1736-1738, 1988.
13. Couto CG, Boudrieau RJ, Zanjani ED: Tumor-associated erythrocytosis in a dog with nasal fibrosarcoma. J Vet Intern Med 3:183-185, 1989.
14. Wysoke JM, Van Heerden J: Polycythemia vera in a dog. J S Afr Vet Assoc 61:182-183, 1990.
15. Meyer HP, Slappendel RJ, Greydanus-van der Putten SW: Polycythemia vera in a dog treated by repeated phlebotomies. Vet Q 15:108-111, 1993.
16. Khanna C, Bienzle D: Polycythemia vera in a cat: Bone marrow culture in erythropoietin-deficient medium. JAAHA 30:45-49, 1994.
17. Watson ADJ, Moore AS, Helfand SC: Primary erythrocytosis in the cat: Treatment with hydroxyurea. J Small Anim Pract 35:320-325, 1994.
18. Evans LM, Caylor KB: Polycythemia vera in a cat and management with hydroxyurea. JAAHA 31:434-438, 1995.
19. Nett CS, Arnold P, Glaus TM: Leeching as initial treatment in a cat with polycythemia vera. J Small Anim Pract 42:554-556, 2001.
20. Sato K, Hikasa Y, Morita T, et al: Secondary erythrocytosis associated with high plasma erythropoietin concentrations in a dog with cecal leiomyosarcoma. JAVMA 220:486-490, 2002.
21. Peterson ME, Randolph JF: Diagnosis of canine primary polycythemia and management with hydroxurea. JAVMA 180:415-418, 1982.
22. Peterson ME, Randolph JF: Diagnosis and treatment of polycythemia, in Kirk RW (ed): Current Veterinary Therapy VIII. Philadelphia, WB Saunders, 1983, pp 406-408.
23. Campbell KL: Diagnosis and management of polycythemia in dogs. Compend Contin Educ Pract Vet 12:542-550, 1990.
24. Hasler AH, Giger U: Polycythemia, in Ettinger SJ, Feldman EC (eds): Textbook of Veterinary Internal Medicine: Diseases of the Dog and Cat, ed 5. Philadelphia, WB Saunders, 2000, pp 203-206.
25. st ACVIM Forum:742-744, 2003.
26. Cote E, Ettinger SJ: Long-term clinical management of right-to-left ("reversed") patent ductus arteriosus in 3 dogs. J Vet Intern Med 15:39-42, 2001.
27. Moore KW, Stepien RL: Hydroxyurea for treatment of polycythemia secondary to right-to-left shunting patent ductus arteriosus in 4 dogs. J Vet Intern Med 15:418-421, 2001.
28. Krantz SB: Erythropoietin. Blood 77:419-434, 1991.
29. Fisher JW, Koury S, Ducey T, Mendel S: Erythropoietin production by interstitial cells of hypoxic monkey kidneys. Br J Haematol 95:27-32, 1996.
30. Wintour EM, Butkus A, Earnest L, Pompolo S: The erythropoietin gene is expressed strongly in the mammalian mesonephric kidney. Blood 88:3349-3353, 1997.
31. Eckardt KU, Kurtz A, Bauer C: Regulation of erythropoietin production is related to proximal tubule function. Am J Physiol 256:942-947, 1989.
32. Eckardt KU, Koury ST, Tan CC, et al: Distribution of erythropoietin producing cells in rat kidneys during hypoxic hypoxia. Kidney Int 43:815-823, 1993.
33. Kaissling B, Hegyi I, Loffing J, LeHir M: Morphology of interstitial cells in the healthy kidney. Anat Embryol 193:303-318, 1972.
34. Giger U: Erythropoietin and its clinical use. Campend Contin Educ Pract Vet 14:25-34, 1992.
35. th ACVIM Forum 143-145, 1991.
36. Fu J-S, Leriora JJL, Rice JC, Fisher JW: Pharmacokinetics of erythropoietin in intact and anephric dogs. J Lab Clin Med 111:669-676, 1983.
37. MacLeod JN, Tetreault JW, Lorschy KA, Gu DN: Expression and bioactivity of recombinant canine erythropoietin. Am J Vet Res 59:1144-1148, 1998.
38. Randolph JF, Stokol T, Scarlett JM, et al: Comparison of biological activity and safety of recombinant canine erythropoietin with that of recombinant human erythropoietin in clinically normal dogs. Am J Vet Res 60:636-642, 1999.
39. Wen D, Boissel JP, Tracy TE, et al: Erythropoietin structure-function relationships: High degree of sequence homology among mammals. Blood 82:1507-1516, 1993.
40. th ACVIM Forum:147-149, 1991.
41. th ACVIM Forum: 603-610, 1991.
42. Cook SM, Lothrop Jr CD: Serum erythropoierin concentrations measured by radioimmunoassay in normal, polycythemic, and anemic dogs and cats. J Vet Intern Med 8:18-25, 1994.
43. Hasler AH, Giger U: Serum erythropoietin values in polycythemic cats. JAAHA 32:294-301, 1996.
44. Pechereau D, Martel P, Braun JP: Plasma erythropoietin concentrations in dogs and cats: Reference values and changes with anaemia and/or renal failure. Res Vet Sci 62:185-188, 1997.
45. Goodnough LT, Monk TG, Andriole GL: Erythropoietin therapy. TV Engl J Med 336:933-938, 1997.
46. Cazzola M, Mercuriali F, Brugnara C: Use of recombinant human erythropoietin outside the setting of uremia. Blood 89:4248-4267, 1997.
47. Bernaudin M, Marti HH, Roussel S, et al: A potential role for erythropoietin in focal permanent cerebral ischemia in mice. J Cereb Blood Flow Metab 19:643-651, 1999.
48. Brines ML, Ghezzi P, Keenan S, et al: Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc Natl Acad Sci USA 97:10526-10531, 2000.
49. Sasaki R, Masuda S, Nagao M: Erythropoietin: Multiple physiologic functions and regulation of biosynthesis. Biosci Biotechnol Biochem 64:1775-1793, 2000.
50. Van Vonderen IK, Meyer HP, Kraus JS, et al: Polyuria and polydipsia and disturbed vasopressin release in two dogs with secondary polycythemia. JAVMA 192:1736-1738, 1988.
51. Furukawa T, Narita M, Sakaue M, et al: Primary familial polycythemia associated with a novel point mutation in the erythropoietin receptor. Br J Haematol 99:222-227, 1997.
52. Kralovics R, Indrak K, Stopka T, et al: Two new EPO receptor mutations: Truncated EPO receptors are most frequently associated with primary familial and congenital polycythemias. Blood 90:2057-2061, 1997.
53. Hammond D, Winnick S: Paraneoplastic erythrocytosis and ectopic erythropoietins. Ann NY Acad Sci 230:219-227, 1974.
54. Altaffer III LF, Chenault Jr OW: Paraneoplastic endocrinopathies associated with renal tumors. J Ural 122:573-579, 1979.
55. Feldman EC, Nelson RW: Beta cell neoplasia: Insulinoma, in Feldman EC, Nelson RW (eds): Canine and Feline Endocrinology and Reproduction, ed 2. Philadelphia, WB Saunders, 1996, p 429.
56. Taylor PC, Dolan G, Ng JP, et al: Efficacy of recombinant interferon-α (rIFN-α) in polycythaemia vera: A study of 17 patients and an analysis of published data. Br J Haematol 92:55-59, 1996.
57. Barbui T, Finazzi G: Risk factors and prevention of vascular complications in polycythemia vera. Semin Thromb Hemost 23:455-461, 1997.
58. Najean Y, Rain JD: Treatment of polycythemia vera: The use of hydroxyurea and pipobroman in 292 patients under the age of 65 years. Blood 90:3370-3377, 1997.
59. Best PJ, Daoud MS, Pittelkow MR, Petitt RM: Hydroxyurea-induced leg ulceration in 14 patients. Ann Intern Med 128:29-32, 1998.
60. Oren R, Beeri M, Hubert A, et al: Effect of theophylline on erythrocytosis in chronic obstructive pulmonary disease. Arch Intern Med 157:1474-1478, 1997.
61. 32P alone or in combination with maintenance therapy using hydroxyurea in 461 patients greater than 65 years of age. Blood 89:2319-2327, 1997.
62. Hoffman R, Wasserman LR: Natural history and management of polycythemia vera. Adv Intern Med 24:250-257, 1979.
63. 32P] treatment of bone marrow disorders in dogs: 11 cases [1970-1987]. JAVMA 194:98-102, 1989.